Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02011945
Title A Phase 1B Study to Investigate the Safety and Preliminary Efficacy for the Combination of Dasatinib Plus Nivolumab in Patients With Chronic Myeloid Leukemia
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Bristol-Myers Squibb
Indications
Therapies
Age Groups: adult
Covered Countries USA | ITA | FRA | ESP | DEU | CAN | AUS

Facility Status City State Zip Country Details
Winship Cancer Institute Atlanta Georgia 30322 United States Details
Dana Farber Cancer Institute. Boston Massachusetts 02215 United States Details
Ut Southwestern Medical Center At Dallas Dallas Texas 75390 United States Details
The University Of Texas MD Anderson Cancer Center Houston Texas 77030 United States Details
Froedtert Hospital & Medical College of Wisconsin Milwaukee Wisconsin 53226 United States Details
Local Institution St Leonards New South Wales 2065 Australia Details
Local Institution Adelaide South Australia 5000 Australia Details
Local Institution Parkville Victoria 3050 Australia Details
QEII Health Sciences Centre-VG Site Halifax Nova Scotia B3H 2Y9 Canada Details
Princess Margaret Cancer Centre Toronto Ontario M5G 2M9 Canada Details
Hopital Maisonneuve-Rosemont Montreal Quebec H1T 2M4 Canada Details
Local Institution Bordeaux 33000 France Details
Campus Virchow Klinikum Der Charite Berlin 13353 Germany Details
Universitaetsklinikum Bonn Bonn 53127 Germany Details
Universitaetsklinikum Carl Gustav Carus Dresden 01307 Germany Details
Universitaetsklinik Frankfurt Frankfurt am Main 60590 Germany Details
Local Institution Napoli 80131 Italy Details
Local Institution Orbassano 10043 Italy Details
Local Institution Roma 00161 Italy Details
Local Institution Madrid 28047 Spain Details
Local Institution Valencia 46010 Spain Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field